GLP-1

weight loss scale weigh measure tape obesity overweight

Biotech

Zealand's dual agonist tied to 11% weight loss in phase 1b

A higher dose of Zealand Pharma's GLP-1/GLP-2 receptor dual agonist reduced mean body weight by 11.6% after 28 weeks in a phase 1b trial.

Gabrielle Masson Jun 18, 2025 3:00pm

liver

South Korean biotech's GLP-1 scores MASH win, reduces weight

Jun 16, 2025 7:22am

obesity overweight weight loss weigh

Metsera posts amylin data, eyes monthly GLP-1 combo

Jun 9, 2025 7:00am

Graphic images of white and black puzzle pieces connecting seamlessly

Eli Lilly taps Camurus' tech to advance long-acting obesity meds

Jun 3, 2025 5:04pm

finance numbers tape money

Regeneron pens $2B pact for Hansoh's potential rival to Zepbound

Jun 2, 2025 8:20am

Novo Nordisk CEO

Fierce Pharma

Novo's longtime CEO Lars Fruergaard Jørgensen to step down

May 16, 2025 9:41am